What changed between these versions
A substantive refinement. v3 structurally modifies the funding mechanism for the Office of Aerospace Medicine by integrating it into the U.S. Code, providing a more permanent statutory basis. Additionally, v3 adds a new subsection requiring evidence-based validation for a specific Aviation Rulemaking Committee recommendation, enhancing the scientific rigor of its implementation.
Overview
A handful of changes concentrated in two sections. · v3 clarifies the statutory basis for funding and strengthens the implementation requirements for specific recommendations by mandating evidence-based validation.
The primary change in v3 is the modification of Section 5, which re-establishes the funding for the Office of Aerospace Medicine by amending section 106(k)(2) of title 49, United States Code, rather than a direct designation within the Act. This provides a more integrated and permanent statutory authorization for the funding. Additionally, a new subsection 6(c) was added, requiring the Administrator to leverage clinical studies and research for recommendation 6 of the Aviation Rulemaking Committee and allowing for commissioning new studies to fill data gaps, thereby strengthening the scientific basis for policy implementation. The core objectives and other provisions of the bill remain consistent between versions.
Major additions
This new subsection mandates that the Administrator must use and cite relevant clinical studies, research, diagnostic manuals, and protocols when informing recommendation 6 of the Mental Health & Aviation Medical Clearances Aviation Rulemaking Committee (ARC). It further authorizes the Administrator to commission additional studies to address any identified data gaps, with a requirement that such studies document the gap and be completed within one year of the Act's enactment.
This addition introduces a critical requirement for evidence-based decision-making specifically for recommendation 6 of the ARC, ensuring that policy implementation is scientifically sound. It also provides a mechanism to proactively address any deficiencies in current data, which could lead to more robust and defensible mental health policies for the aviation workforce.
Modifications
This modification integrates the funding provision directly into the permanent statutory framework of the U.S. Code, specifically under the FAA's general authority for appropriations. While the funding amount, duration, and purpose remain unchanged, this change provides a more enduring and established legal basis for the allocation of funds to the Office of Aerospace Medicine, potentially streamlining future appropriations and oversight.
Before
In v2, Section 5 directly designated not more than $15,000,000 for fiscal years 2026 through 2028 from amounts made available pursuant to section 106(k)(1) of title 49, United States Code, for specific activities related to improving the capacity of the Office of Aerospace Medicine.
After
In v3, Section 5 amends section 106(k)(2) of title 49, United States Code, by adding a new subparagraph (E). This new subparagraph then designates the same amount of not more than $15,000,000 for fiscal years 2026 through 2028 for the identical specific activities related to improving the capacity of the Office of Aerospace Medicine.
Scope
Meaningful expansion or narrowing — The changes are concentrated in two specific sections: Section 5, which addresses funding for the Office of Aerospace Medicine, and Section 6, which outlines the implementation of Aviation Rulemaking Committee recommendations. — v3 represents a refinement within the existing policy direction. It clarifies the statutory basis for funding and strengthens the scientific rigor required for implementing specific recommendations, rather than altering the overall policy goals. — The modification to Section 5 directly interacts with and expands an existing provision in Title 49, U.S. Code (Section 106(k)(2)), integrating the bill's funding mechanism into broader federal law. The addition in Section 6(c) adds a new requirement for a specific ARC recommendation.
Impact analysis
Federal Aviation Administration (FAA) and its Office of Aerospace Medicine
Procedural change, leading to more stable funding authorization.
The funding mechanism for the Office of Aerospace Medicine's capacity improvements is now permanently codified within Title 49, U.S. Code, rather than being a standalone provision in this Act.
Administrator in implementing Aviation Rulemaking Committee (ARC) recommendations
Procedural change, leading to increased scientific rigor and evidence-based decision-making for a specific recommendation.
The Administrator is now explicitly required to leverage and cite clinical studies and research for recommendation 6 of the ARC, and has the authority to commission new studies to fill data gaps for this specific recommendation.